Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome

BACKGROUND: Metabolic syndrome (MetS) is a clinical condition potentially promoting the development of atherosclerotic disease. To date, the clinical impact of elevated serum homocysteine (Hcy) levels in MetS is still under discussion. The aim of this cross sectional study was to evaluate the relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Piazzolla, Giuseppina, Candigliota, Mafalda, Fanelli, Margherita, Castrovilli, Anna, Berardi, Elsa, Antonica, Gianfranco, Battaglia, Stefano, Solfrizzi, Vincenzo, Sabbà, Carlo, Tortorella, Cosimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815401/
https://www.ncbi.nlm.nih.gov/pubmed/31673296
http://dx.doi.org/10.1186/s13098-019-0484-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815401/
https://www.ncbi.nlm.nih.gov/pubmed/31673296
http://dx.doi.org/10.1186/s13098-019-0484-0

Ejemplares similares